Patients in our ACS group showed elevated levels of IL-5, IL-13, and additionally, IL-6, a marker of monocytic inflammation, tended to negatively influence changes in FVC and FEV1 in patients with ACS. The gene discussed is IL6; the disease is acute chest syndrome.